Evidence map›Paper›PMID 28664359›Full record

ArticleEuropean journal of clinical pharmacology2017

Adverse cardiac events associated with incident opioid drug use among older adults with COPD.

Nicholas T Vozoris, Xuesong Wang, Peter C Austin, Douglas S Lee, Anne L Stephenson, Denis E O'Donnell, Sudeep S Gill, Paula A Rochon

Abstract read
PubMed Publisher
In one paragraph

Article in European journal of clinical pharmacology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
3.9field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Survival implications of prescription opioid and benzodiazepine use in lung transplant recipients: Analysis of linked transplant registry and pharmacy fill records.The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation · 2021
    Article
  7. Observational
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

Nicholas T VozorisDivision of Respirology, Department of Medicine, St. Michael's Hospital, 30 Bond Street, Toronto, ON, M5B 1W8, Canada. nick.vozoris@utoronto.ca.
Xuesong WangInstitute for Clinical Evaluative Sciences, Toronto, ON, Canada.
Peter C AustinInstitute for Clinical Evaluative Sciences, Toronto, ON, Canada.
Douglas S LeeDepartment of Medicine, University of Toronto, Toronto, ON, Canada.
Anne L StephensonDivision of Respirology, Department of Medicine, St. Michael's Hospital, 30 Bond Street, Toronto, ON, M5B 1W8, Canada.
Denis E O'DonnellDepartment of Medicine, Queen's University, Kingston, ON, Canada.
Sudeep S GillInstitute for Clinical Evaluative Sciences, Toronto, ON, Canada.
Paula A RochonDepartment of Medicine, University of Toronto, Toronto, ON, Canada.
Institute for Clinical Evaluative Sciences · CAUniversity of Toronto · CAQueen's University · CASt Michael's Hospital · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeWe evaluated whether incident opioid drug use was associated with adverse cardiac events among older adults with chronic obstructive pulmonary disease (COPD).

methodsThis was an exploratory, retrospective cohort study using health administrative data from Ontario, Canada, from 2008 to 2013. Using a validated algorithm, we identified adults aged 66 years and older with non-palliative COPD. Hazard ratios (HR) were estimated for adverse cardiac events within 30 days of incident opioid receipt compared to controls using inverse probability of treatment weighting using the propensity score.

resultsThere were 134,408 community-dwelling individuals and 14,685 long-term care residents with COPD identified, 67.0 and 60.6% of whom received an incident opioid. Incident use of any opioid was associated with significantly decreased rates of emergency room (ER) visits and hospitalizations for congestive heart failure (CHF) among community-dwelling older adults (HR 0.84; 95% CI 0.73-0.97), but significantly increased rates of ischemic heart disease (IHD)-related mortality among long-term care residents (HR 2.15; 95% CI 1.50-3.09). In the community-dwelling group, users of more potent opioid-only agents without aspirin or acetaminophen combined had significantly increased rates of ER visits and hospitalizations for IHD (HR 1.38; 95% CI 1.08-1.77) and IHD-related mortality (HR 1.83; 95% CI 1.32-2.53).

conclusionsNew opioid use was associated with elevated rates of IHD-related morbidity and mortality among older adults with COPD. Adverse cardiac events may need to be considered when administering new opioids to older adults with COPD, but further studies are required to establish if the observed associations are causal or related to residual confounding.

Indexed as

Drug-Related Side Effects and Adverse ReactionsAgedAged, 80 and overAnalgesics, OpioidCardiotoxicityCohort StudiesHeartHospitalizationHumansIndependent LivingPropensity ScorePulmonary Disease, Chronic ObstructiveRetrospective StudiesAnalgesics, OpioidCardiacCOPDDrug safetyOpioidsPharmacoepidemiology

Identifiers

PMID28664359
OpenAlexW2731559721

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.